
Lastuss-CT Tablet
Marketer
FDC Ltd
Salt Composition
Dextromethorphan Hydrobromide (10mg)
Overview Lastuss-CT Tablet
Lastuss-CT tablets offer relief from dry cough as an antitussive agent. Their mechanism involves suppressing the brain's cough reflex. Administered orally, this medication can be taken with or without food, following your doctor's prescribed dosage and duration. Dosage adjustments consider the formulation (tablet, syrup, etc.), age, and existing health conditions. Complete the entire course of treatment, even with symptom improvement. If a dose is missed, take it immediately upon recollection. Adequate fluid intake is recommended. Self-medication and recommending this medicine to others are strictly prohibited. Store safely away from children; overdose can be harmful. Dizziness is a potential side effect; avoid driving or tasks requiring alertness. Some patients may experience rashes or diarrhea.
Uses of Lastuss-CT Tablet
Persistent, unproductive cough
Major Benefits of Lastuss-CT Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Lastuss-CT Tablets can be taken with or without food, although consistent timing is recommended.
Common Side effects of Lastuss-CT Tablet:
- Sleepiness
- Dizziness
- Nausea
- Confusion
How to use Lastuss-CT Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or break it. Lastuss-CT Tablets can be consumed with or without food, though consistent timing is recommended.
How Lastuss-CT Tablet works:
Cogni-Tuss tablets effectively quell coughs by inhibiting the brain's cough reflex center. They belong to the antitussive class of medications.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Lastuss-CT Tablet with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Lastuss-CT Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Lastuss-CT Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Lastuss-CT Tablet use.
KidneySAFE IF PRESCRIBED
The use of Lastuss-CT Tablets in patients with kidney disease appears to pose minimal risk. Available evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
LiverCAUTION
Patients with significant hepatic impairment should exercise caution when using Lastuss-CT Tablets. Dosage modification for Lastuss-CT Tablets may be necessary. Physician consultation is advised.
What if you forget to take Lastuss-CT Tablet :
Should you forget a Lastuss-CT Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lastuss-CT Tablet
| Label | Value |
|---|---|
| Chemical Category | Dextrorphan Methyl Analog |
| Developing Habits | No. |
| Treatment Category | Breathing |
